were normal but some pupilloconstriction did occur, probably as a result of interruption of sympathetic fitbres.
The doll's head and caloric tests, well described by Plum and Posner (1966) , may help to locate the brain-stem lesion. Nordgren et al. (1971) , like ourselves, usually found conjugate lateral eye movement to be absent both voluntarily and reflexly as judged by the doll's head and caloric tests. This probably results from destruction of the lateral gaze centres on both sides in addition to the ventral pontine damage. Two of our patients, however, displayed tonic abduction of the ipsilateral eye towards the ear irrigated with ice water. This indicates that the medial longitudinal bundle is bilaterally destroyed but that the abducens nucleus is intact. This point is well illustrated in fig. 1 , where the area of complete destruction has spared the sixth nerve nucleus and falls just short of the medial longitudinal bundle but is almost certainly impairing its function.
At first sight i-t is surprising that patients who have such an extensive lesion are not unconscious. A possible explanation (Nordgren et al., 1971 ) is that so far as the brain stem is concerned consciousness depends on the integrity of the reticular formation in the rostral pons and midbrain, areas which are preserved in the locked-in syndrome. Indeed the E.E.G.s from all our subjects (Hawkes and Bryan-Smyth, 1974) were normal or nearly so, in keeping with their alert state.
The locked-in syndrome is often overlooked and the misdiagnosis of true coma made, probably because of a failure to test voluntary vertical conjugate gaze, which is often the only movement of which such patients are capable. Many were referred to our E.E.G. department as "unexplained coma" but almost all their records were those of wakefulness (Hawkes and Bryan-Smyth, 1974) .
In contrast to the series of Nordgren et al. (1971) our patients were distinctly younger (mean age 39 years) and survived longer (mean survival 14 months) whereas their patients were mostly over 60 and died within one week. Despite our longer survival rate the two survivors can hardly be said to have made a worthwhile recovery. Both regained speech and some limb movement but remained confined to a wheelchair.
It has been suggested (Jennett and Plum, 1972) that the terms "locked in," "akinetic mutism," etc., be abandoned and grouped as "persistent vegetative state." Some patients with the latter condition, however, will be conscious and others not, a distinction obviously of clinical importance. Though the term "locked in" is perhaps not ideal it does help to draw attention to the plight of vegetative patients who are aware of their environment and need sympathetic handling. Journal, 1974, 4, 382-385 Summary Serial estimations of plasma carcinoembryonic antigen (C.E.A.) levels have been carried out in 220 patients with colorectal carcinomas who had potentially and apparently curative surgery. In a two-year follow-up period 53 patients developed recurrences or metastases. In 36 of these patients sustained rises in plasma C.E.A. titres Introduction Previous studies have shown that estimation of the plasma levels of carcinoembryonic antigen (C.E.A.) (Gold and Freedman, 1965) has limited value in the diagnosis or differential diagnosis of localized carcinomas of the colon and rectum (Moore et al., 1971; Holyoke et al., 1972; Laurence et al., 1972; Zamcheck et al., 1972; Mach et al., 1973; Elias et al., 1974; Skarin et al., 1974 C.E.A. level was considered to be normal if it remained consistently below 20 ng/ml and abnormal if it rose to and remained at levels in excess of 40 ng/ml. These levels were chosen on the basis of our previous experience, which showed that levels over 40 ng/ml were associated solely with malignant neoplasms, whereas reactive and inflammatory conditions could yield results in the normal range or up to 40 ng/ml (Laurence et al., 1972) .
Role of Serial
A further 250 patients under surveillance have been omitted from the present results because of an inadequate follow-up time or because the plasma C.E.A. values had risen temporarily to or remained at levels between 20 and 40 ng/ml. Further study and more time will be required to assess the significance of such levels in that group.
Methods
The technique for collecting plasma and the double-antibody radioimmunoassay used to measure C.E.A. have been described in detail previously (Laurence et al., 1972 tIn two the levels had returned to preoperative values of between 30 and 40 ng/ml only when recurrences were detected. They are classed as "unchanged" in table I. <20  2  1  1  1  4  2  1  20-40  2  1  1  >40  1  2  2  2   Total   J  1  6  1  1  3  6  3  2 Mach et al., 1973) attention has focused on the potential role of plasma C.E.A. surveillance as a method to facilitate the earlier detection of recurrent or metastatic colorectal carcinomas in the postoperative follow-up period. Preliminary reports have given grounds for cautious optimism (Neville and Laurence, 1974; Sorokin et al., 1974) . In the present series three patterns in the level of plasma C.E.A. were observed-namely, progressively rising or sustained high levels ( >40 ng/ml), transient increases, and continuously normal values (<20 ng/ml). As yet no recurrence has been found in any patient with a transient rise; the significance of this is the subject of further study.
A C.E.A. level in excess of 40 ng/ml was chosen as truly abnormal because levels between 20 and 40 ng/ml can occur and seldom exceed 40 ng/ml in association with a variety of non-neoplastic inflammatory and regenerative disorders (Laurence et al., 1972) .
With the use of these criteria raised plasma levels of C.E.A. were detected in 36 of the 53 subjects in whom recurrences became clinically overt. In 26 of these patients the plasma levels became raised and rose further for between three and 18 months before the detection of the recurrent or metastatic disease. These trends in plasma C.E.A. levels in subjects with confirmed metastatic disease may allow us to conclude that the other 17 subjects with values in excess of 40 ng/ml though apparently clinically well also had latent tumours (table I) .
Consequently it may be calculated from this information that 760' of patients-that is, 53 out of 70-will develop rises in plasma C.E.A. levels irrespective of the preoperative level synchronously with the development of recurrent or metastatic disease but usually before it becomes overt. Therefore at present the serial assay of plasma C.E.A. represents an important addition to the armamentarium available to the clinician for the detection of recurrent and metastatic tumours of colorectal origin and its use as a screening procedure during the postoperative follow-up phase is to be recommended.
The availability to the clinician of this type of informationnamely, that recurrent disease may already be present-may provide justification for "second-look" surgery (Wangensteen et al., 1954) or the institution of chemotherapeutic or radiotherapeutic procedures or both at an earlier phase in the progression of the disease. Whether this will result in improved survival is unknown.
Most patients in the present series had plasma C.E.A. values continuously in the normal range (tables I and IV). As this does not preclude the presence of tumour and its subsequent overt recurrence, however, there is a need to evolve further methods which will help to ascertain beforehand which tumours will recur with normal plasma C.E.A. levels and which will be associated with raised levels. While the site of the metastases and the volume of tumour may be important (table III) table  IV shows that when preoperative levels were raised recurrence was also associated with high levels.
Functional methods of examining primary tumours associated with normal preoperative plasma levels for the presence or absence in the tumour of C.E.A. may be of value and seem worth further study. The direct extraction and assay of the tumours for C.E.A., the use of immunoperoxidase staining techniques for its localization in or on cells, or the establishment of the tumours in organ and monolayer cultures (Breborowicz et al., 1973) to detect whether they can produce and release C.E.A. into the medium seem appropriate ancillary investigations which the pathology laboratory could undertake.
As noted above we have excluded from the present series a number of other patients being followed up after operation as their plasma C.E.A. values had risen from normal to between 20 and 40 ng/ml. While this value may eventually be used to indicate at an even earlier stage the presence of recurrent tumour further time is needed to ascertain or refute this conclusion. The concomitant measurement of other tumour associated antigens such as AFP (Thompson et al., 1974) or serum enzymes such as y-glutamyl transpeptidase (yGT) (Steele et al., 1974) may help to clarify the situation, particularly when liver metastases are suspected. Preliminary data to be reported in detail elsewhere indicate that about 50°h of this group with C.E.A. values between 20 and 40 ng/ml also had raised y-GT serum levels (Cooper et al., 1974) .
Chu (1974) presented tentative evidence which suggests that the preoperative level of plasma C.E.A. might act as a prognostic index. Tumours associated with high levels were reported to recur earlier. We cannot confirm this at present; neither can it be refuted (tables V and VI). Our data tend to suggest that the level of preoperative C.E.A. may be a function of the existence of wider dissemination of tumour than can be detected at operation (tables V and VI) (Laurence et al., 1972) .
